COMPANY
Mile High Compounds LLC
Mile High Compounds LLC: warning letter recipient for Retatrutide, Semaglutide, Tirzepatide, as stated by public registers.
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Retatrutide | Unapproved New Drugs Sold Over the Internet, 2026-03-31 Regulator FDA warning letters |
|---|---|
| Semaglutide | Unapproved New Drugs Sold Over the Internet, 2026-03-31 Regulator FDA warning letters |
| Tirzepatide | Unapproved New Drugs Sold Over the Internet, 2026-03-31 Regulator FDA warning letters |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.